Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2017-01-31

FDA Approved: TETRABENAZINE — Original Application (Precision Dose Inc.)

View source ↗

Summary

FDA approved the original ANDA for tetrabenazine by Precision Dose Inc., enabling a generic version of the Huntington's disease chorea treatment.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Tetrabenazine (tetrabenazine)

Snippet

ORIG AP for TETRABENAZINE (TETRABENAZINE)